Free Trial

STAAR Surgical (STAA) Stock Price, News & Analysis

+0.04 (+0.09%)
(As of 05/22/2024 ET)
Today's Range
50-Day Range
52-Week Range
344,351 shs
Average Volume
507,934 shs
Market Capitalization
$2.09 billion
P/E Ratio
Dividend Yield
Price Target

STAAR Surgical MarketRank™ Stock Analysis

Analyst Rating
2.40 Rating Score
10.8% Upside
$47.13 Price Target
Short Interest
9.02% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
1.61mentions of STAAR Surgical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$66,735 Bought Last Quarter
Proj. Earnings Growth
From $0.08 to $0.46 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.74 out of 5 stars

Medical Sector

81st out of 920 stocks

Ophthalmic Goods Industry

1st out of 7 stocks

STAA stock logo

About STAAR Surgical Stock (NASDAQ:STAA)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA Stock Price History

STAA Stock News Headlines

What 7 Analyst Ratings Have To Say About Staar Surgical
Staar Surgical Co STAA
See More Headlines
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Ophthalmic goods
Health Care Supplies
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
10 Analysts


Net Income
$21.35 million
Pretax Margin


Sales & Book Value

Annual Sales
$322.42 million
Cash Flow
$0.73 per share
Book Value
$7.99 per share


Free Float
Market Cap
$2.09 billion

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

STAA Stock Analysis - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" STAA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STAA, but not buy additional shares or sell existing shares.
View STAA analyst ratings
or view top-rated stocks.

What is STAAR Surgical's stock price target for 2024?

10 analysts have issued 1-year price objectives for STAAR Surgical's stock. Their STAA share price targets range from $35.00 to $57.00. On average, they expect the company's stock price to reach $47.13 in the next year. This suggests a possible upside of 10.8% from the stock's current price.
View analysts price targets for STAA
or view top-rated stocks among Wall Street analysts.

How have STAA shares performed in 2024?

STAAR Surgical's stock was trading at $31.21 at the start of the year. Since then, STAA stock has increased by 36.3% and is now trading at $42.55.
View the best growth stocks for 2024 here

When is STAAR Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 7th 2024.
View our STAA earnings forecast

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings results on Tuesday, May, 7th. The medical instruments supplier reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.12. The medical instruments supplier had revenue of $77.40 million for the quarter, compared to the consensus estimate of $75.34 million. STAAR Surgical had a trailing twelve-month return on equity of 6.83% and a net margin of 4.69%. The company's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.05 earnings per share.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical issued an update on its FY 2024 earnings guidance on Wednesday, April, 17th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $340.0 million-$340.0 million, compared to the consensus revenue estimate of $337.2 million.

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.15%), Baillie Gifford & Co. (8.38%), Defender Capital LLC. (1.49%), Geneva Capital Management LLC (1.45%), Yunqi Capital Ltd (1.05%) and APEIRON CAPITAL Ltd (0.72%). Insiders that own company stock include Aimee S Weisner, Broadwood Partners, LP, Caren L Mason, Elizabeth Yeu Lin, Hans-Martin Blickensdoerfer, James E Francese, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends

How do I buy shares of STAAR Surgical?

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does STAAR Surgical have any subsidiaries?
The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
This page (NASDAQ:STAA) was last updated on 5/23/2024 by Staff

From Our Partners